Conditioner & Hair Mask: Cationic Conditioning Deposition & Detangling Mechanism

Overview #

Cationic conditioning is not complicated chemistry. What makes it hard is deposition — getting the right amount of active onto the right substrate, consistently, at scale. Most conditioning failures we see aren’t formulation errors in the traditional sense. They’re deposition failures: wrong charge density, wrong molecular weight, wrong rinse profile. The result is either greasy buildup or no perceivable softness at all. This article walks through the clinical evidence behind the three actives we use most — polyquaternium-10, cetrimonium chloride, and hydrolyzed keratin — and what that evidence actually means when you’re writing claims for EU, US, and NMPA markets.

How Cationic Deposition Actually Works (And Where It Fails) #

Hair fiber carries a net negative charge, roughly −10 to −40 mV depending on damage level. Cationic actives deposit through electrostatic attraction. Simple in theory. In practice, the deposition window is narrow.

At conditioning concentrations above 3% cetrimonium chloride, we start seeing competitive adsorption — the cationic molecules form bilayers on the fiber surface instead of monolayers, and the outer layer rinses off, taking some of the inner layer with it. Net result: less conditioning than a 1.5% formula. We’ve seen this in our own lab more than once, and it still surprises clients when we show them the combability data.

The other failure mode is pH. Drop below pH 4.0 and the fiber cuticle swells differently, changing the available anionic sites. Go above pH 6.5 and you’re reducing the charge differential enough that deposition efficiency drops by roughly 30–40% in our internal testing. We target pH 4.5–5.5 for all rinse-off conditioning formats.

Molecular weight matters too, but not in the way most people assume. High-MW polyquaterniums (above 500,000 Da) deposit heavily on the outer cuticle and create a film that feels smooth immediately post-rinse but can build up over 4–6 wash cycles. Low-MW variants penetrate the cuticle layer more readily but give less immediate slip. For a leave-in treatment, we almost always go low-MW. For a rinse-off mask, we blend both.

Scale-up note: this is where projects go sideways. At 50 kg lab scale, mixing sequence and temperature are easy to control. At 2,000 kg production, the time between adding the cationic phase and reaching homogenization can stretch to 15–20 minutes. In that window, if the batch temperature drops below 65°C, you get premature cationic aggregation — visible as white specks in the finished product. We now require a minimum hold temperature of 68°C during the cationic addition phase on all production batches.

Clinical Evidence: Three Actives, What the Data Actually Shows #

Polyquaternium-10 (PQ-10)

PQ-10 is the workhorse. It’s in probably 70% of the rinse-off conditioners we manufacture. The clinical evidence for combability improvement is solid. One well-designed study (randomized, single-blind, n=42, 8-week duration) measured wet combing force reduction using a tensile testing rig. Formulas containing 0.5% PQ-10 showed a 38% reduction in wet combing force versus the surfactant-only control. Dry combing force reduction was 22%. The study used a standardized European hair panel — medium-porosity, chemically untreated — so results on bleached or relaxed hair will differ. We’ve run our own internal combability panels on high-porosity hair and typically see 25–30% wet combing improvement at the same concentration, which is still meaningful but lower than the published figure.

What the published data doesn’t cover well is wash durability. In our stability and performance testing, PQ-10 deposition shows measurable decline after 10 consecutive wash cycles. By cycle 15, the combability benefit is roughly half of the initial measurement. This matters if you’re making “long-lasting” claims.

Cetrimonium Chloride (CTAC)

CTAC is a small-molecule quaternary ammonium compound. It works differently from PQ-10 — less film-forming, more direct fiber lubrication. The clinical evidence here is actually more nuanced than most suppliers will tell you.

A double-blind, split-head study (n=36, 6 weeks) comparing 1% CTAC versus 2% CTAC in an identical emulsion base found no statistically significant difference in perceived softness scores between the two concentrations (consumer panel, 7-point hedonic scale, p=0.12). What did differ was frizz control — the 2% formula scored 1.4 points higher on a 10-point frizz scale. This tells us CTAC’s primary mechanism at these concentrations is cuticle alignment, not bulk lubrication. We use this data internally when clients ask us to reduce CTAC concentration for cost reasons. Honestly, going from 2% to 1% probably won’t hurt softness perception, but it will hurt frizz performance.

CTAC also has a regulatory ceiling in the EU: EU Cosmetics Regulation 1223/2009 restricts rinse-off use to 2.5% and leave-on to 1.0%. We’ve had clients come to us with briefs calling for 3% CTAC in a leave-on serum. That’s a non-starter in the EU market.

Hydrolyzed Keratin

This is where the evidence gets more complicated. Hydrolyzed keratin is popular — brand owners love the story — but the clinical data is uneven. Molecular weight of the hydrolysate matters enormously, and most published studies don’t specify it clearly enough to be directly actionable.

The strongest data we’ve seen comes from a randomized controlled trial (n=60, 12 weeks, twice-weekly application) using a low-MW hydrolyzed keratin fraction (average MW 1,000–2,000 Da). Tensile strength improvement was 18% versus placebo at week 12. Fiber diameter uniformity (measured by scanning electron microscopy cross-sections) improved by 11%. These are real numbers. But the study used a leave-on treatment at 5% active concentration — not a rinse-off conditioner. In our rinse-off testing at 2–3% hydrolyzed keratin, tensile strength improvement drops to roughly 6–8%, which is at the edge of what’s clinically meaningful.

We’re still not fully convinced the rinse-off keratin story is as strong as the marketing suggests. The deposition efficiency in a rinse-off format is inherently limited. Our current position: use hydrolyzed keratin in rinse-off products for the ingredient story and the marginal benefit, but don’t build primary claims around it unless you’re in a leave-on format.

For deeper context on protein-based actives and their interaction with the hair fiber matrix, see our peptide and growth factor formulation notes.

Evidence Strength Comparison Table #

BTMS deserves a note. It’s our preferred emulsifying quat for hair masks because it gives a cleaner rinse feel than CTAC-based emulsions. The published clinical data is thinner than we’d like, but our internal panel data (n=24, 4-week wash study) consistently shows 29% dry combing improvement. We use it, we trust it, but we’re honest with clients that the published evidence base is not as deep as PQ-10.

Where Most Brands Get the Claim Language Wrong #

This is usually where projects go sideways — not in the lab, but in the claim review.

“Repairs damaged hair” is a structure/function claim in the US and a borderline therapeutic claim in the EU. The FDA Cosmetics Guidelines are clear that cosmetics cannot claim to repair or restore biological structure. “Helps hair feel stronger” is acceptable. “Repairs broken bonds” is not — that’s drug territory. We push back on this brief almost every time.

In the EU, the SCCS Scientific Opinion framework requires that claims be truthful, evidenced, honest, fair, and not misleading. “Clinically proven detangling” requires you to have the study. If your evidence is supplier data on a raw material, not a finished product study, the claim is technically unsupported under EU guidelines. This catches a lot of brands off guard.

NMPA is a different story. Under NMPA Cosmetic Regulation, hair care products fall under general cosmetics unless they claim to treat scalp conditions. “Smooth,” “soft,” “detangle,” and “shine” are all acceptable functional claims without clinical dossier requirements. What NMPA does require is ingredient registration — any new ingredient not on the approved list requires a separate filing that can take 6–12 months. We flag this early in every project brief for the China market.

For brands targeting all three markets simultaneously, our practical guidance: build your claim architecture around the most restrictive market (EU), then verify FDA alignment, then confirm NMPA ingredient status. Don’t write the EU claim last — it’s the hardest to retrofit.

For more on how we approach regulatory-aligned formulation from the start, see our acid exfoliation technology notes — the claim substantiation principles transfer directly to conditioning actives.

One more thing on ICH stability: if you’re submitting a clinical dossier, your finished product stability data should follow ICH Stability Guidelines — 40°C/75% RH for 6 months minimum. We’ve had EU retail partners reject claim dossiers because the stability data was generated at 37°C, not 40°C. Small difference, real consequence.

The Hard Truth About Silicone-Free Conditioning #

A lot of clean beauty brands come to us asking for silicone-free conditioning that performs like a silicone formula. We understand the brief. We also have to be honest about it.

Dimethicone and amodimethicone are genuinely hard to replace at equivalent sensory performance. Amodimethicone in particular — the amino-functional variant — deposits selectively on damaged fiber sites through the same electrostatic mechanism as cationic polymers, but with a slip and shine profile that plant-based alternatives haven’t matched in our testing. We’ve tried. Meadowfoam seed oil, rice bran wax, plant-derived squalane — all good ingredients, none of them replicate the wet slip of 0.5% amodimethicone in a rinse-off formula.

What we can do: a well-designed cationic polymer blend (PQ-10 plus a low-MW polyquaternium-7) with a fatty alcohol emollient base (cetyl alcohol at 4–6%, behentrimonium methosulfate at 2–3%) gets you to roughly 80% of the silicone sensory profile. For most consumers, that’s acceptable. For fine hair types, it’s often actually preferable — silicone buildup is a real complaint on fine hair, and the polymer-based formula rinses cleaner.

It’s not a perfect solution.

Formulation Notes for Brand Partners #

When a brand comes to us with a conditioning brief, the first questions we ask are: What market? What hair type is the primary target? And what’s the on-pack claim you’re committed to?

Those three answers change everything. A “detangling conditioner” for the EU market targeting Afro-textured hair needs a completely different cationic architecture than a “lightweight daily conditioner” for fine Asian hair in the China market. The EU version will likely run 2–2.5% CTAC plus 0.5% PQ-10 plus a heavier fatty alcohol base. The China version might use 0.3% PQ-10, no CTAC, and a lighter ester emollient to avoid the heavy feel that fine hair consumers in that market consistently reject in our sensory panels.

MOQ and cost matter here too. Airless packaging for a premium hair mask adds $0.40–$0.80 per unit. At MOQ 1,000 units, most indie brands can’t absorb that. We usually recommend standard HDPE jars with an inner seal for masks — it’s not as premium, but it protects the formula and keeps unit cost manageable.

If you’re targeting a “clinically proven” on-pack claim, budget for a finished product consumer study — minimum n=30, 8 weeks, with validated combability or tensile measurement. That’s typically a $15,000–$25,000 investment before you factor in formulation development. We can refer you to CROs we’ve worked with, but the timeline is 4–6 months minimum. Plan accordingly.

Frequently Asked Questions #

Q: We want to say “clinically proven detangling” on pack — what do we actually need to back that up?

You need a finished product study, not raw material supplier data. Minimum n=30, with a validated instrumental measurement (wet combing force via tensile rig is the standard) and a control arm. For the EU market, the study should be conducted on the finished formula at the exact concentration you’re selling — not a prototype. Budget 4–6 months and roughly $15,000–$20,000 for a credible study.

Q: Can we use 3% cetrimonium chloride in a leave-on hair serum for the EU market?

No. EU Cosmetics Regulation caps CTAC at 1.0% in leave-on products. At 3%, you’re out of compliance before the product ships. We’d reformulate using behentrimonium methosulfate or a polyquaternium blend to hit your sensory target within the regulatory limit.

Q: Our supplier says their hydrolyzed keratin “penetrates the cortex” — can we use that claim?

Only if you have the data for your finished product. Supplier claims on raw materials don’t transfer automatically to finished product claims. In our rinse-off testing, low-MW hydrolyzed keratin (under 2,000 Da) does show measurable cortex interaction, but at typical rinse-off concentrations of 2–3%, the effect is modest — roughly 6–8% tensile improvement. “Helps strengthen hair” is defensible. “Penetrates the cortex” is a mechanism claim that needs its own substantiation.

Q: We’re launching in China — do we need to register hydrolyzed keratin with NMPA?

If it’s on the existing NMPA approved ingredient list, no separate filing is needed. Most standard hydrolyzed keratins are listed. What you do need to verify is the specific MW fraction and processing method — some modified keratin derivatives require separate registration. We check this at brief intake for every China-market project. Don’t assume — the filing delay if you get it wrong is 6–12 months.

Q: What’s the minimum conditioning formula that actually works for a budget rinse-off conditioner?

Honestly, 0.5% PQ-10, 2% cetyl alcohol, 1.5% CTAC, and a simple fragrance at 0.3% will give you measurable combability improvement at a very low COGS. It won’t win sensory panels against a premium formula, but it performs. We’ve launched products at this spec for private label clients who needed to hit a $2.50 retail price point. It works. Don’t over-engineer a budget SKU.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.